These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15142476)

  • 1. Psychopharmacology of borderline personality disorder.
    Raj YP
    Curr Psychiatry Rep; 2004 Jun; 6(3):225-31. PubMed ID: 15142476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics?
    Abraham PF; Calabrese JR
    J Affect Disord; 2008 Nov; 111(1):21-30. PubMed ID: 18304647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent trends in the pharmacotherapy of personality disorders.
    Markovitz PJ
    J Pers Disord; 2004 Feb; 18(1):90-101. PubMed ID: 15061346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy of borderline personality disorder.
    Hirschfeld RM
    J Clin Psychiatry; 1997; 58 Suppl 14():48-52; discussion 53. PubMed ID: 9418746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing aggressive behavior in patients with obsessive-compulsive disorder and borderline personality disorder.
    Hollander E
    J Clin Psychiatry; 1999; 60 Suppl 15():38-44. PubMed ID: 10418814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State of the art in the pharmacologic treatment of borderline personality disorder.
    Feurino L; Silk KR
    Curr Psychiatry Rep; 2011 Feb; 13(1):69-75. PubMed ID: 21140245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials.
    Lieb K; Völlm B; Rücker G; Timmer A; Stoffers JM
    Br J Psychiatry; 2010 Jan; 196(1):4-12. PubMed ID: 20044651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological treatment for patients with borderline personality disorder: practice and study results].
    Schwerthöffer D; Bäuml J; Rentrop M
    Fortschr Neurol Psychiatr; 2013 Aug; 81(8):437-43. PubMed ID: 23939557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of personality disorder.
    Bateman AW; Gunderson J; Mulder R
    Lancet; 2015 Feb; 385(9969):735-43. PubMed ID: 25706219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on pharmacotherapy of borderline personality disorder.
    Zanarini MC
    Curr Psychiatry Rep; 2004 Feb; 6(1):66-70. PubMed ID: 14738708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopharmacologic approaches to the borderline patient.
    Zisook S; Ricketts JE
    Hillside J Clin Psychiatry; 1988; 10(1):55-70. PubMed ID: 2900799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychopharmacology of borderline personality disorder: a review.
    Cowdry RW
    J Clin Psychiatry; 1987 Aug; 48 Suppl():15-25. PubMed ID: 2886493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychopharmacologic treatment of borderline personality disorder.
    Ripoll LH
    Dialogues Clin Neurosci; 2013 Jun; 15(2):213-24. PubMed ID: 24174895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Borderline states: pharmacotherapy and psychobiology of personality. A discussion of Soloff's article.
    Rosenberg R
    Acta Psychiatr Scand Suppl; 1994; 379():56-60. PubMed ID: 7912036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medications in the treatment of borderline personality disorder 2006.
    Mercer D
    Curr Psychiatry Rep; 2007 Feb; 9(1):53-62. PubMed ID: 17257515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personality trait dimensions and the pharmacological treatment of borderline personality disorder.
    Saunders EF; Silk KR
    J Clin Psychopharmacol; 2009 Oct; 29(5):461-7. PubMed ID: 19745646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.
    Zanarini MC; Frankenburg FR; Parachini EA
    J Clin Psychiatry; 2004 Jul; 65(7):903-7. PubMed ID: 15291677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug treatment of the personality disorders.
    Stein G
    Br J Psychiatry; 1992 Aug; 161():167-84. PubMed ID: 1355689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological interventions for borderline personality disorder.
    Stoffers J; Völlm BA; Rücker G; Timmer A; Huband N; Lieb K
    Cochrane Database Syst Rev; 2010 Jun; (6):CD005653. PubMed ID: 20556762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome of psychopharmacologic treatment of borderline and schizotypal personality disordered subjects.
    Coccaro EF
    J Clin Psychiatry; 1998; 59 Suppl 1():30-5; discussion 36-7. PubMed ID: 9448667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.